Lifetime Risk of Male Genital Cancers Shows Sharp Global Inequality, GLOBOCAN 2022 Analysis Finds
A GLOBOCAN 2022 analysis of 185 countries shows that lifetime risk of penile, prostate, and testicular cancers is highest in ...
A GLOBOCAN 2022 analysis of 185 countries shows that lifetime risk of penile, prostate, and testicular cancers is highest in ...
A scientific review details the clinical momentum, biological complexity, and dosimetric challenges shaping the next era of precision radiopharmaceutical cancer ...
A meta-analysis of fourteen observational studies found no statistically significant difference in prostate cancer risk between men with high and ...
A retrospective cohort of 97 prostatectomy patients in Jordan found clinical and pathological T staging agreed in only 61.9 percent ...
A retrospective single-center study of 76 prostate cancer patients found that raising the injected activity of Lu-PSMA-I&T from 7.4 to ...
A systematic review of sixteen studies finds that emerging serum and urine protein biomarkers, including PHI, PSP94/PSA ratio, ANXA3 and ...
An optimized SNEDDS formulation of flutamide achieved rapid self-emulsification, near-complete drug release, and stronger cytotoxicity against PC-3 prostate cancer cells ...
An integrated in silico and in vitro study finds that clinically used fluorinated PSMA PET radiopharmaceuticals share a conserved binding ...
A commercial AI tool for prostate MRI achieved a numerically higher AUC with its quasi-continuous risk score than with fixed ...
A new review explains how reactive oxygen species shift from essential cellular signals to drivers of prostate cancer, bladder cancer ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine